TFS Financial TFSL Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies

TFS FinancialTFSL

863.8K+1,645%

Baxter InternationalBAX

4.1M+295%

RBC BearingsRBC

124-81.6%

Coeur MiningCDE

43.3K+203%

Charles River LaboratoriesCRL

40K—

Jazz PharmaceuticalsJAZZ

340K-36.6%

Other financials

Income statement

See full

Revenue$85.2M+7.7%

Net income$23.2M+10.6%

EPS (diluted)$0.08+14.3%

Balance sheet

See full

Cash & equivalents$437.3M-5.7%

Total debt$1.7B+61.1%

Total equity$1.9B+1.4%

Total assets$17.5B+2.2%

Cash flow

See full

Operating cash flow$17.6M-16.9%

CapEx$4.2M-38.9%

Free cash flow$13.4M-6.2%

Valuation

See full

Market cap$4.6B+13.3%

Enterprise value$5.84B+27.7%

P/E49.5×-0.3×

P/S13.7×+0.3×

Profitability

See full

Net margin27.6%+0.9pp

FCF margin52%—

Returns & leverage

See full

Return on equity4.9%+0.6pp

Debt / equity0.9×+0.3×

Where this comes from

Reported directly by TFS Financial in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.

The official record: TFS Financial’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →

Ask your AI about TFS Financial's share-based compensation arrangement by share-based payment award, options, expirations in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TFS Financial's share-based compensation arrangement by share-based payment award, options, expirations in period?: TFS Financial (TFSL) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 863.8K in Q3 2025.
What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?: The number of stock options that reached the end of their contractual term without being exercised by the holders. This indicates the portion of equity incentives that expired worthless, often due to the market price remaining below the exercise price.